IL-1β increases abundance and activity of the negative transcriptional regulator yin yang-1 (YY1) in neonatal rat cardiac myocytes

被引:21
作者
Patten, M
Wang, WZ
Aminololama-Shakeri, S
Burson, M
Long, CS
机构
[1] Denver Hlth Med Ctr, Cardiol Sect, Denver, CO 80204 USA
[2] Univ Colorado, Denver, CO 80204 USA
关键词
IL-1; beta; transcription factor; myocyte; gene expression; phosphorylation;
D O I
10.1006/jmcc.2000.1169
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Current research from both clinical and basic science perspectives indicates that cytokines play an important role in the genesis of cardiovascular pathology. Specifically, levels of cytokines such as interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6) have been found to be elevated in both acute myocardial injury as well as situations of chronic dysfunction. Further, therapies directed primarily at interfering with cytokine action have suggested that such an immunomodulatory approach may be beneficial in some of these circumstances of myocardial injury. lire recently reported that IL-1 beta induces a hypertrophic slate in cultured neonatal rat cardiac myocytes that differs from other well described hypertrophic phenotypes in terms of myocardial gene expression (such as skeletal alpha-actin, sACT), an effect that appeared to co-localize with that of the negative regulator yin yang-1 (YY1),(1) In the present study, we further localize the area in the sACT promoter responsible for the IL-1 effect. These investigations indicate that sequences in and around the third upstream serum response element (SRE3) bind YY1 and are required for IL-1 beta mediated repression. This element is also capable of transferring both IL-1 beta and YY1-mediated transcriptional repression to a heterologous promoter, In support of an IL-1 beta induced post-translational modification of YY1 that results in an increase in DNA-binding activity, (32)beta-labeling experiments reveal an increase in phosphorylated YY1 in IL-1 beta treated cells and phosphatase-treated myocyte nuclear proteins lose their ability to bind to the YY1 site. In summary these results provide evidence that sequences within the SRE3 of the skeletal actin promoter represent an IL-1 beta response clement and suggest that IL-1 beta activates the negative transcription factor YY1 by both transcriptional and post-transcriptional mechanisms. (C) 2000 Academic Press.
引用
收藏
页码:1341 / 1352
页数:12
相关论文
共 56 条
[1]   Characterization of the transcriptional regulator YY1 - The bipartite transactivation domain is independent of interaction with the TATA box-binding protein, transcription factor IIB, TAF(II)55, or cAMP-responsive element-binding protein (CBP)-binding protein [J].
Austen, M ;
Luscher, B ;
LuscherFirzlaff, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (03) :1709-1717
[2]   CHARACTERIZATION OF HUCRBP (YY1, NF-E1, DELTA) - A TRANSCRIPTION FACTOR THAT BINDS THE REGULATORY REGIONS OF MANY VIRAL AND CELLULAR GENES [J].
BECKER, KG ;
JEDLICKA, P ;
TEMPLETON, NS ;
LIOTTA, L ;
OZATO, K .
GENE, 1994, 150 (02) :259-266
[3]   BINDING OF THE UBIQUITOUS NUCLEAR TRANSCRIPTION FACTOR YY1 TO A CIS REGULATORY SEQUENCE IN THE HUMAN LINE-1 TRANSPOSABLE ELEMENT [J].
BECKER, KG ;
SWERGOLD, GD ;
OZATO, K ;
THAYER, RE .
HUMAN MOLECULAR GENETICS, 1993, 2 (10) :1697-1702
[4]  
BOGOYEVITCH MA, 1995, J BIOL CHEM, V270, P29710
[5]   Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart - p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion [J].
Bogoyevitch, MA ;
GillespieBrown, J ;
Ketterman, AJ ;
Fuller, SJ ;
BenLevy, R ;
Ashworth, A ;
Marshall, CJ ;
Sugden, PH .
CIRCULATION RESEARCH, 1996, 79 (02) :162-173
[6]   Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats [J].
Bozkurt, B ;
Kribbs, SB ;
Clubb, FJ ;
Michael, LH ;
Didenko, VV ;
Hornsby, PJ ;
Seta, Y ;
Oral, H ;
Spinale, FG ;
Mann, DL .
CIRCULATION, 1998, 97 (14) :1382-1391
[7]  
BUSHEL P, 1995, ONCOGENE, V10, P1361
[8]  
Chen CY, 1996, DEV GENET, V19, P119, DOI 10.1002/(SICI)1520-6408(1996)19:2<119::AID-DVG3>3.0.CO
[9]  
2-C
[10]  
Chen CY, 1996, MOL CELL BIOL, V16, P6372